CYPHERPUNK TECHNOLOGIES INC. Proceeds from Issuance of Private Placement
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Proceeds from Issuance of Private Placement of $40.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-03-16
- CYPHERPUNK TECHNOLOGIES INC. proceeds from issuance of private placement for the quarter ending 2024-12-31 was $0.00.
- CYPHERPUNK TECHNOLOGIES INC. proceeds from issuance of private placement for the quarter ending 2024-09-30 was $0.00.
- CYPHERPUNK TECHNOLOGIES INC. proceeds from issuance of private placement for the quarter ending 2017-12-31 was $8.00M.
- CYPHERPUNK TECHNOLOGIES INC. proceeds from issuance of private placement for the quarter ending 2017-09-30 was $0.00.
- CYPHERPUNK TECHNOLOGIES INC. proceeds from issuance of private placement for fiscal 2024 was $40.00M.
- CYPHERPUNK TECHNOLOGIES INC. proceeds from issuance of private placement for fiscal 2017 was $18.00M.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $40.00M 10-K · filed 2026-03-16 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $40.00M 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $40.00M 10-Q · filed 2025-08-14 | ||||
| 2017-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $8.00M derived: sum of 2 quarters · filed 2019-04-01 | $8.00M derived: sum of 3 quarters · filed 2019-04-01 | $18.00M 10-K · filed 2019-04-01 | |
| 2017-11-14 | $18.00M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | $10.00M 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $10.00M 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | $10.00M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |